Comparative Pharmacology
Head-to-head clinical analysis: FREAMINE III 3 W ELECTROLYTES versus FREAMINE III 8 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FREAMINE III 3 W ELECTROLYTES versus FREAMINE III 8 5.
FREAMINE III 3% W/ ELECTROLYTES vs FREAMINE III 8.5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Provides essential and non-essential amino acids for protein synthesis, maintaining nitrogen balance, and supporting metabolic functions. Electrolytes help maintain acid-base balance and osmotic pressure.
FREAMINE III 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, nitrogen balance maintenance, and tissue repair. It acts as a substrate for protein anabolism in patients unable to tolerate adequate oral or enteral intake.
Administered intravenously. Typical adult dose: 500-1000 mL/day (15-30 g amino acids) infused at a rate not exceeding 0.1 g/kg/hour. Frequency: continuous or intermittent infusion as part of parenteral nutrition.
Intravenous infusion; typical adult dose is 0.8-1.5 g amino acids/kg/day (equivalent to 9.4-17.6 mL/kg/day of Freamine III 8.5%). Initiate at lower end and titrate to metabolic needs. Administer via central or peripheral line with dextrose and electrolytes as part of parenteral nutrition.
None Documented
None Documented
Variable; based on individual amino acid components (alanine ~2.3h, glycine ~1.5h, etc.); clinical context: continuous infusion achieves steady state within 8-12h
Terminal elimination half-life of infused amino acids is approximately 15-30 minutes for most, but albumin synthesis half-life is 20-22 days; clinical context: continuous infusion needed for nitrogen balance.
Renal excretion of amino acid nitrogen as urea (85-90%) and other nitrogenous wastes; minimal biliary/fecal (<5%)
Renal: 90-95% of infused amino acids are reabsorbed; excess nitrogen excreted as urea (80-90% of nitrogen load) and ammonia (<10%). Biliary/fecal: negligible (<5%).
Category C
Category C
Parenteral nutrition amino acid
Parenteral nutrition amino acid